“Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.”, Contemp Clin Trials Commun, vol. 30, p. 101025, 2022.
, “Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.”, J Pediatr, vol. 211, pp. 27-32.e1, 2019.
, “Pharmacokinetics of Clindamycin in Obese and Non-obese Children”, Antimicrob Agents Chemother, vol. 61, no. 4, 2017.
, “Population Pharmacokinetics of Intravenous Acyclovir in Preterm and Term Infants”, Pediatr Infect Dis J, vol. 33, no. 1, pp. 42-9, 2014.
, “Determining Population and Developmental Pharmacokinetics of Metronidazole using Plasma and Dried Blood Spot Samples from Premature Infants”, Pediatr Infect Dis J, vol. 32, no. 9, pp. 956-61, 2013.
, “Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.”, Clin Infect Dis, vol. 55, no. 11, pp. 1495-502, 2012.
,